Drug | Receptor activity | Predominant clinical effects | |||
Alpha-1 | Beta-1 | Beta-2 | Dopaminergic | ||
Phenylephrine | +++ | 0 | 0 | 0 | SVR ↑ ↑, CO ↔/↑ |
Norepinephrine | +++ | ++ | 0 | 0 | SVR ↑ ↑, CO ↔/↑ |
Epinephrine | +++ | +++ | ++ | 0 | CO ↑ ↑, SVR ↓ (low dose) SVR/↑ (higher dose) |
Dopamine (mcg/kg/min)* | |||||
0.5 to 2. | 0 | + | 0 | ++ | CO |
5. to 10. | + | ++ | 0 | ++ | CO ↑, SVR ↑ |
10. to 20. | ++ | ++ | 0 | ++ | SVR ↑ ↑ |
Dobutamine | 0/+ | +++ | ++ | 0 | CO ↑, SVR ↓ |
Isoproterenol | 0 | +++ | +++ | 0 | CO ↑, SVR ↓ |